358 related articles for article (PubMed ID: 25615945)
1. Advanced targeted nanomedicine.
Pereira MC; Reshetnyak YK; Andreev OA
J Biotechnol; 2015 May; 202():88-97. PubMed ID: 25615945
[TBL] [Abstract][Full Text] [Related]
2. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.
Andreev OA; Engelman DM; Reshetnyak YK
Mol Membr Biol; 2010 Oct; 27(7):341-52. PubMed ID: 20939768
[TBL] [Abstract][Full Text] [Related]
3. Applications of pHLIP Technology for Cancer Imaging and Therapy.
Wyatt LC; Lewis JS; Andreev OA; Reshetnyak YK; Engelman DM
Trends Biotechnol; 2017 Jul; 35(7):653-664. PubMed ID: 28438340
[TBL] [Abstract][Full Text] [Related]
4. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy.
Gessner I; Neundorf I
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268473
[TBL] [Abstract][Full Text] [Related]
7. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
Tay LM; Xu C
Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
[No Abstract] [Full Text] [Related]
8. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
9. pHLIP Peptides Target Acidity in Activated Macrophages.
Visca H; DuPont M; Moshnikova A; Crawford T; Engelman DM; Andreev OA; Reshetnyak YK
Mol Imaging Biol; 2022 Dec; 24(6):874-885. PubMed ID: 35604527
[TBL] [Abstract][Full Text] [Related]
10. The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy.
Shi Y; van der Meel R; Chen X; Lammers T
Theranostics; 2020; 10(17):7921-7924. PubMed ID: 32685029
[TBL] [Abstract][Full Text] [Related]
11. Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.
Deacon JC; Engelman DM; Barrera FN
Arch Biochem Biophys; 2015 Jan; 565():40-8. PubMed ID: 25444855
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
13. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
Gao H; Zhang Q; Yang Y; Jiang X; He Q
Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
[TBL] [Abstract][Full Text] [Related]
14. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
15. Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.
Varghese OP; Liu J; Sundaram K; Hilborn J; Oommen OP
Biomater Sci; 2016 Aug; 4(9):1310-3. PubMed ID: 27431007
[TBL] [Abstract][Full Text] [Related]
16. Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application.
Hao Y; Wang L; Zhang B; Li D; Meng D; Shi J; Zhang H; Zhang Z; Zhang Y
Int J Nanomedicine; 2016; 11():1759-78. PubMed ID: 27199556
[TBL] [Abstract][Full Text] [Related]
17. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
[TBL] [Abstract][Full Text] [Related]
18. Recent nanotheranostic approaches in cancer research.
Gupta D; Roy P; Sharma R; Kasana R; Rathore P; Gupta TK
Clin Exp Med; 2024 Jan; 24(1):8. PubMed ID: 38240834
[TBL] [Abstract][Full Text] [Related]
19. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
Small; 2017 Mar; 13(10):. PubMed ID: 28026115
[TBL] [Abstract][Full Text] [Related]
20. Cancer nanomedicines targeting tumor extracellular pH.
Tian L; Bae YH
Colloids Surf B Biointerfaces; 2012 Nov; 99():116-26. PubMed ID: 22078927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]